A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
四位分析师对恩安特制药的专业展望
Decoding Analyst Ratings: A...4 analysts have shared their evaluations of Enanta Pharma (NASDAQ:ENTA) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三个月内，有4位分析师对Enanta Pharma (纳斯达克:ENTA) 进行了评估，表达了看好和看淡的不同观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.25, along with a high estimate of $27.00 and a low estimate of $10.00. A decline of 1.22% from the prior average price target is evident in the current average.
分析师提供更深入的见解，已确定了12个月的价格目标，显示平均目标为20.25美元，最高估价为27.00美元，最低估价为10.00美元。从先前的平均价格目标来看，当前的平均价格目标下降了1.22%。
Decoding Analyst Ratings: A...
分析师评...
登录免费看全文
登录/注册
资讯热榜
更新时间